Ferumoxytol

非莫妥尔

Report date: 2026/04/17 20:02:02
NME

Base Information

Drug NameFerumoxytol
Drug Alias Name多聚糖超顺磁氧化铁RiensoFerahemeAMI-7228Code-7228
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIron replacements
TargetsNot applicable
Therapy Area/IndicationsBrain metastasesInflammationDiabetes Mellitus +[35
Global Approved IndicationsAnemia, Iron-DeficiencyAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2009/06/30
Country/TerritoryCanadaUnited StatesUkraine +[22
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAmag Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active IndicationsBrain metastasesDiabetes MellitusAnemia, Iron-Deficiency +[14
Inactive IndicationsInflammationSarcoidosisAnemia +[21

Other Information

ATC CodeB03
Related LinksKEGG